Global Tuberculous Lymphadenitis Treatment Market, By Causative Agent (Mycobacterium Tuberculosis, Mycobacterium Bovis, Mycobacterium Kansasii, Mycobacterium Fortuitum, Mycobacterium Marinum, Mycobacterium Ulcerans), Stage (Lymphadenitis, Periadenitis, Cold Abscess, ‘Collar Stud’ Abscess, Sinus), Treatment (Drugs, Surgical Excision), End-Users (Hospitals, Supportive Centres, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.